Table 2 |
|||||||||
|
Average Cost per DALY in relation to the null of interventions to reduce Colorectal Cancer in selected WHO subregions |
|||||||||
|
AFRE |
AMRA |
EURC |
|||||||
|
|
|||||||||
|
Intervention |
COST |
DALYS saved |
COST per DALY |
COST |
DALYS saved |
COST per DALY |
COST |
DALYS saved |
COST per DALY |
|
I$ (mill) |
I$ |
I$ (mill) |
I$ |
I$ (mill) |
I$ |
||||
|
|
|||||||||
|
Current Scenario (a) |
116 |
27,546 |
4,206 |
64,937 |
14,135,241 |
4,594 |
4,677 |
1,801,461 |
2,596 |
|
|
|||||||||
|
FOB1 |
4,193 |
98,525 |
42,557 |
11,745 |
1,603,126 |
7,326 |
5,440 |
548,649 |
9,915 |
|
|
|||||||||
|
FOB2 |
2,222 |
66,502 |
33,410 |
6,448 |
1,082,872 |
5,954 |
2,954 |
370,055 |
7,984 |
|
|
|||||||||
|
SIG5 |
1,407 |
90,077 |
15,620 |
6,807 |
1,463,474 |
4,651 |
2,716 |
492,378 |
5,516 |
|
|
|||||||||
|
COL10 |
1,561 |
117,977 |
13,231 |
7,858 |
2,020,645 |
3,889 |
3,070 |
661,542 |
4,641 |
|
|
|||||||||
|
FOB1SIG5 |
4,915 |
121,374 |
40,491 |
15,989 |
1,969,383 |
8,119 |
7,069 |
665,773 |
10,617 |
|
|
|||||||||
|
FOB50 |
380 |
12,222 |
31,055 |
1,082 |
198,064 |
5,465 |
526 |
59,843 |
8,786 |
|
|
|||||||||
|
SIG50 |
531 |
41,910 |
12,669 |
2,446 |
679,950 |
3,597 |
984 |
205,514 |
4,786 |
|
|
|||||||||
|
COL50 |
1,040 |
91,092 |
11,415 |
5,027 |
1,491,646 |
3,370 |
1,980 |
449,523 |
4,404 |
|
|
|||||||||
|
FOBSIG50 |
478 |
46,981 |
10,183 |
3,032 |
762,325 |
3,977 |
860 |
230,391 |
3,734 |
|
|
|||||||||
|
RX |
1,394 |
837,066 |
1,666 |
73,225 |
14,991,673 |
4,884 |
12,145 |
4,200,308 |
2,891 |
|
|
|||||||||
|
FOB1RX |
5,461 |
912,458 |
5,984 |
77,579 |
16,300,533 |
4,759 |
16,481 |
4,630,614 |
3,559 |
|
|
|||||||||
|
FOB2RX |
3,524 |
890,163 |
3,959 |
74,346 |
15,929,042 |
4,667 |
14,328 |
4,507,099 |
3,179 |
|
|
|||||||||
|
SIG5RX |
2,706 |
896,387 |
3,019 |
75,839 |
15,864,896 |
4,780 |
14,100 |
4,518,157 |
3,121 |
|
|
|||||||||
|
COL10RX |
2,844 |
909,822 |
3,126 |
76,031 |
16,131,444 |
4,713 |
14,301 |
4,604,861 |
3,106 |
|
|
|||||||||
|
FOB1SIG5RX |
5,110 |
922,577 |
5,539 |
74,917 |
16,382,245 |
4,573 |
15,584 |
4,672,483 |
3,335 |
|
|
|||||||||
|
FOB50RX |
1,758 |
850,239 |
2,067 |
74,130 |
15,200,680 |
4,877 |
12,633 |
4,275,966 |
2,954 |
|
|
|||||||||
|
SIG50RX |
1,897 |
867,915 |
2,185 |
74,793 |
15,433,538 |
4,846 |
12,975 |
4,357,438 |
2,978 |
|
|
|||||||||
|
COL50RX |
2,377 |
899,415 |
2,643 |
76,236 |
15,881,346 |
4,800 |
13,780 |
4,509,360 |
3,056 |
|
|
|||||||||
|
FOBSIG50RX |
2,188 |
871,888 |
2,509 |
75,660 |
15,494,325 |
4,883 |
14,712 |
4,377,287 |
3,361 |
|
|
|||||||||
|
FVCAMP |
275 |
7,618 |
36,074 |
366 |
84,085 |
4,354 |
360 |
17,804 |
20,222 |
|
|
|||||||||
|
FVCAMPRX |
1,681 |
842,102 |
1,996 |
73,476 |
15,037,102 |
4,886 |
12,513 |
4,210,885 |
2,972 |
|
|
|||||||||
|
DRE1 |
818 |
9,438 |
86,676 |
2,370 |
153,861 |
15,401 |
1,008 |
52,939 |
19,038 |
|
|
|||||||||
|
DRE1RX |
2,421 |
846,382 |
2,861 |
75,207 |
15,145,147 |
4,966 |
13,299 |
4,259,810 |
3,122 |
|
|
|||||||||
|
Cost-effective threshold |
4,728 |
94,431 |
20,748 |
||||||
|
Very cost-effective threshold |
1,576 |
31,477 |
6,916 |
||||||
|
|
|||||||||
|
(Discounted at 3% per annum & Age-Weighted). Note: Interventions that fall on expansion path are in bold type. (a) The current scenario represents the interventions which are currently being provided in the sub-regions. This differs from the reference strategy, the null, where no intervention or treatment is provided. |
|||||||||
|
Ginsberg et al. Cost Effectiveness and Resource Allocation 2010 8:2 doi:10.1186/1478-7547-8-2 |
|||||||||
